Wolverine Trading
LXRX icon

Wolverine Trading’s Lexicon Pharmaceuticals LXRX Stock Holding History

Wolverine Trading’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$43.8K Buy
+31,500
New +$35.7K ﹤0.01% 5444
2025
Q1 		– Sell
-10,100
Closed -$7.27K – 5388
2024
Q4 		$7.27K Buy
10,100
+100
+1% +$121 ﹤0.01% 5167
2024
Q3 		$16K Sell
10,000
-7,300
-42% -$13K ﹤0.01% 4659
2024
Q2 		$29.1K Sell
17,300
-3,700
-18% -$6.64K ﹤0.01% 4293
2024
Q1 		$50.4K Buy
21,000
+8,700
+71% +$18.7K ﹤0.01% 4214
2023
Q4 		$18.8K Sell
12,300
-1,100
-8% -$1.31K ﹤0.01% 4375
2023
Q3 		$14.6K Sell
13,400
-13,500
-50% -$23.7K ﹤0.01% 4352
2023
Q2 		$58.4K Buy
+26,900
New +$71.4K ﹤0.01% 3905
2022
Q1 		– Sell
-24,900
Closed -$104K – 6010
2021
Q4 		$104K Buy
24,900
+10,200
+69% +$49.5K ﹤0.01% 5079
2021
Q3 		$72K Buy
14,700
+2,800
+24% +$11.5K ﹤0.01% 5911
2021
Q2 		$60K Buy
+11,900
New +$57.3K ﹤0.01% 5565
2020
Q1 		– Sell
-10,900
Closed -$45K – 4991
2019
Q4 		$45K Sell
10,900
-8,600
-44% -$33.1K ﹤0.01% 4480
2019
Q3 		$67K Sell
19,500
-9,100
-32% -$28.2K ﹤0.01% 3979
2019
Q2 		$180K Sell
28,600
-36,100
-56% -$216K ﹤0.01% 3770
2019
Q1 		$360K Buy
+64,700
New +$393K ﹤0.01% 3150
2018
Q3 		– Sell
-17,500
Closed -$150K – 5467
2018
Q2 		$150K Hold
17,500
– – ﹤0.01% 4566
2018
Q1 		$150K Buy
+17,500
New +$162K ﹤0.01% 4566
2017
Q4 		– Sell
-17,000
Closed -$209K – 5244
2017
Q3 		$209K Buy
+17,000
New +$251K ﹤0.01% 3748

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wolverine Trading's LXRX Position: Q3 2025 in Review

Wolverine Trading opened a new position in Lexicon Pharmaceuticals (LXRX) in Q3 2025: 21,191 shares worth $29.5K. The stake represents ﹤0.01% of the portfolio and ranks #5501 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in LXRX as recently as Q3 2024.

Wolverine Trading first reported a position in LXRX in Q1 2019 and has held it in 13 quarters since. The position peaked at $202K in Q1 2019. 123 funds tracked by Wall St. Rank hold LXRX as of Q3 2025.

  • Wolverine Trading held 21,191 shares of Lexicon Pharmaceuticals worth $29.5K as of Q3 2025.
  • Lexicon Pharmaceuticals was a new Wolverine Trading position in Q3 2025.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5501 holding.
  • Wolverine Trading first reported a position in Lexicon Pharmaceuticals in Q1 2019 and has held it in 13 quarters since.
  • Wolverine Trading's Lexicon Pharmaceuticals position peaked at $202K in Q1 2019.
  • 123 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.